|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/16 | |
| A61K 38/31 | |||
| A61K 49/00 |
| (11) | Patento numeris | 2359809 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10175382.0 |
| Europos patento paraiškos padavimo data | 2006-12-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-08-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 0526247 | 2005-12-22 | GB | |
| 06119086 | 2006-08-17 | EP |
| (72) |
Petersen, Holger, DE
Ahlheim, Markus, DE
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
| Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |